• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.65% Nasdaq Down 1.89%

    Galena Biopharma, Inc. (GALE)

    -NasdaqCM
    1.71 0.01(0.58%) Jan 27, 4:00PM EST
    Add to Portfolio
    Prev Close:1.72
    Open:1.72
    Bid:1.61 x 200
    Ask:1.96 x 1600
    1y Target Est:5.71
    Beta:2.2
    Earnings Date:Mar 16 - Mar 20 (Est.)
    Day's Range:1.69 - 1.74
    52wk Range:1.43 - 5.70
    Volume:755,625
    Avg Vol (3m):1,601,980
    Market Cap:207.69M
    P/E (ttm):N/A
    EPS (ttm):-0.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GALE

    Comparison

    Symbol% ChgMkt Cap
    GALEDown 0.58%207.69M
    CELG97.73B
    VSTM192.91M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.35
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology treatments that address major unmet medical needs to advance cancer care. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback